Publications by authors named "Anmol Aggarwal"

Claim this Profile
T
Toxicokinetic profiling of VRP-034: Evaluating its potential in mitigating polymyxin-B-associated nephrotoxicity.
Kamlesh Vishwakarma, Anmol Bisht, Parveen Kumar, Satish Kumar, Jawed Akhter, Anmol Aggarwal

Int J Antimicrob Agents· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
scCamAge: A context-aware prediction engine for cellular age, aging-associated bioactivities, and morphometrics.
Vishakha Gautam, Subhadeep Duari, Saveena Solanki, Mudit Gupta, Aayushi Mittal, Anmol Aggarwal

Cell Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Rheological, Mechanical, and Viscoelastic Properties of Silica-Filled SSBR and BR Model Compounds.
Anmol Aggarwal, Nico Hackel, Fabian Grunert, Sybill Ilisch, Mario Beiner

Polymers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model.
Anurag Payasi, Manoj Kumar Yadav, Saransh Chaudhary, Anmol Aggarwal

Antimicrob Agents Chemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence uncovers carcinogenic human metabolites.
Aayushi Mittal, Sanjay Kumar Mohanty, Vishakha Gautam, Sakshi Arora, Sheetanshu Saproo, Anmol Aggarwal

Nat Chem Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of a biosimilar enoxaparin (Cloti-Xa™) and its innovator (Clexane ): A single-dose, randomized, double-blind, two-period, two-treatment, two-sequence, crossover, balanced study in healthy human subjects.
Sumit Saxena, Manu Chaudhary, Saransh Chaudhary, Anmol Aggarwal

Pharmacol Res Perspect· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats.
Dilip Roy, Amol Kulkarni, Manu Chaudhary, Saransh Chaudhary, Anurag Payasi, Anmol Aggarwal

Antibiotics (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis